This company has been marked as potentially delisted and may not be actively trading. Medicines (MDCO) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock MDCO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Major Investment Alert: Adage Capital’s Bold Move in Praxis Precision Medicines!October 17 at 10:11 PM | tipranks.comRevolution Medicines, Disc Medicine, American Express And Other Big Stocks Moving Higher On FridayOctober 17 at 12:30 PM | benzinga.comBeOne Medicines Ltd. Announces Name and Stock Short Name ChangeOctober 17 at 9:50 AM | tipranks.comPromising Prospects for Revolution Medicines: Buy Rating Affirmed on Daraxonrasib’s CNPV DesignationOctober 17 at 3:50 AM | tipranks.comPraxis Precision Medicines Announces Pricing of $525 Million Public Offering of Common Stock and Pre-Funded WarrantsOctober 16 at 11:50 PM | quiverquant.comQRevolution Medicines Receives FDA Voucher for Daraxonrasib Under National Priority Voucher Pilot ProgramOctober 16 at 8:11 PM | quiverquant.comQPraxis Precision’s tremor-drug trial succeeds where others have failed. The stock is skyrocketing.October 16 at 4:50 PM | marketwatch.comBuy Rating for Praxis Precision Medicines Driven by Ulixacaltamide’s Promising Phase III Results and Market PotentialOctober 16 at 3:10 PM | tipranks.comOptimistic Buy Rating for Praxis Precision Medicines Amid Positive Phase 3 Results and Strategic AdvancementsOctober 16 at 12:51 PM | tipranks.comBuy Rating Affirmed for Praxis Precision Medicines Following Positive Phase 3 Study ResultsOctober 16 at 11:50 AM | tipranks.comEnerpac Tool Group Posts Upbeat Results, Joins Praxis Precision Medicines, J B Hunt, Salesforce And Other Big Stocks Moving Higher On ThursdayOctober 16 at 10:51 AM | benzinga.comAmerica Is Heavily Reliant on China for Raw Materials in MedicinesOctober 15 at 12:11 PM | nytimes.comBeOne Medicines: Sonrotoclax Could Set Next Stage Of Growth For Hematology PipelineOctober 14, 2025 | seekingalpha.comTYK Medicines, Inc. Strengthens Governance with New Audit CommitteeOctober 14, 2025 | tipranks.comTYK Medicines, Inc Announces Key Governance Changes at Upcoming EGMOctober 14, 2025 | tipranks.comTYK Medicines, Inc Proposes Structural Reforms and Incentive SchemeOctober 14, 2025 | tipranks.comBeOne Medicines’ Sonrotoclax Granted Breakthrough Therapy Designation by U.S. FDAOctober 13, 2025 | financialpost.comFEverest Medicines Grants Options to Chairman to Enhance GovernanceOctober 10, 2025 | tipranks.comEverest Medicines Announces Board Composition to Strengthen GovernanceOctober 9, 2025 | tipranks.comEverest Medicines Announces Leadership ChangesOctober 9, 2025 | tipranks.comTYK Medicines Announces Book Closure for EGM on Articles AmendmentOctober 9, 2025 | tipranks.comBeOne Medicines Ltd. Announces Grant of RSUs and PSUsOctober 8, 2025 | tipranks.comCellectar Biosciences Receives EMA Advice on Drug FilingOctober 6, 2025 | tipranks.comHow BeOne Medicines, An IBD 50 Stock, Is Taking On Big Names In Cancer TreatmentOctober 4, 2025 | investors.comEverest Medicines Grants New Options and Awards to EmployeesOctober 2, 2025 | tipranks.comDr. Reddy’s Receives Positive CHMP Opinion for AVT03 BiosimilarSeptember 22, 2025 | tipranks.comTakeda and VELA to Ship Medicines Across the Atlantic Using First-of-its-Kind Wind-Powered TrimaranSeptember 16, 2025 | financialpost.comFTYK Medicines Announces Board Composition and Committee RolesSeptember 15, 2025 | tipranks.comTYK Medicines Faces Temporary Non-Compliance Following Director ResignationSeptember 15, 2025 | tipranks.comBeOne Medicines Completes Employee Share Purchase PlanSeptember 12, 2025 | tipranks.comBeOne Medicines (ONC) Reports Positive Phase 1/2 Results for Sonrotoclax in MCLSeptember 12, 2025 | insidermonkey.comAnalysts Raise Price Targets Following Strong Data From Revolution Medicines' Pancreatic Cancer DrugSeptember 11, 2025 | benzinga.comRevolution Medicines: Shares Soar On Pancreatic Cancer Study Win - I'm SoldSeptember 11, 2025 | seekingalpha.comPromising Position of Revolution Medicines’ Zoldonrasib Justifies Buy RatingSeptember 11, 2025 | tipranks.comPromising Potential of Daraxonrasib in Pancreatic Cancer Boosts Buy Rating for Revolution MedicinesSeptember 11, 2025 | tipranks.comRevolution Medicines rises on daraxonrasib data that supports phase 3 programSeptember 10, 2025 | seekingalpha.comRevolution Medicines Reports Promising Phase 1 Study ResultsSeptember 10, 2025 | tipranks.comRevolution Medicines Reports Promising Long-term Data for Daraxonrasib in Metastatic Pancreatic Cancer and Announces Phase 3 Trial PlansSeptember 10, 2025 | quiverquant.comQAntares Vision Group Partners with Gambia’s MCA for Pharmaceutical TraceabilitySeptember 10, 2025 | tipranks.comTrump Weighs Crackdown on Medicines From ChinaSeptember 10, 2025 | nytimes.comWHO Updates List Of Essential Medicines To Include Key Cancer, Diabetes Treatments September 8, 2025 | rttnews.comFDA Tightens Grip On Safe Weight Loss Drugs, WHO Adds Them To Essential Medicines ListSeptember 7, 2025 | benzinga.comPraxis Precision Medicines Signs New Sales AgreementSeptember 5, 2025 | tipranks.comPraxis Precision Medicines to Present at Upcoming Investor Conferences in September 2025September 4, 2025 | quiverquant.comQBeOne Medicines Ltd. Launches New Employee Share Purchase Plan OfferingSeptember 4, 2025 | tipranks.comBeOne Medicines Ltd. Announces Grant of Restricted Share Units to EmployeesSeptember 4, 2025 | tipranks.comBiophytis Secures EMA Approval for Phase 2 Obesity TrialSeptember 3, 2025 | tipranks.comTYK Medicines Announces Board Composition and RolesAugust 31, 2025 | tipranks.comTYK Medicines Enhances Treasury Operations with Strategic InvestmentsAugust 31, 2025 | tipranks.comTYK Medicines Reports Reduced Losses in H1 2025August 31, 2025 | tipranks.com Get Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for MDCO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MDCO Media Mentions By Week MDCO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MDCO News Sentiment▼0.000.47▲Average Medical News Sentiment MDCO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MDCO Articles This Week▼177▲MDCO Articles Average Week Get the Latest News and Ratings for MDCO and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Medicines and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies RPRX News Today JAZZ News Today CORT News Today PRGO News Today SUPN News Today NKTR News Today PCRX News Today OMER News Today ASMB News Today CPIX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MDCO) was last updated on 10/18/2025 by MarketBeat.com Staff From Our PartnersBuy alert: Move $1,000 before Tesla’s Optimus launchElon's $1,000,000,000,000 payday Elon Musk just made his biggest insider purchase of Tesla stock ever. He's...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredTrump’s “Smart Dollar” just went mainstream"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredShots officially fired…Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the righ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Medicines Company Please log in to your account or sign up in order to add this asset to your watchlist. Share Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
